Gosebruch Henry O

CIK 00016596254 companiesAGOURA HILLS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001659625

Recent Transactions

50 trades

Disposition to Issuer
ACELYRIN, Inc.
Common Stock
2025-05-21−50,000→ 0 total
Disposition to Issuer
ACELYRIN, Inc.
Director Stock Option (right to buy)
2025-05-21−92,158→ 0 total
Disposition to Issuer
ACELYRIN, Inc.
Director Stock Option (right to buy)
2025-05-21−155,450→ 0 total
Award
ACELYRIN, Inc.
Director Stock Option (right to buy)
2024-06-07+92,158→ 92,158 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2024-02-14+160,000→ 160,000 total
Award
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-02-14+80,000→ 462,345 total
Purchase
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19$12.62/sh+15,000→ 15,000 total
Other
ACELYRIN, Inc.
Director Stock Option (right to buy)
2023-05-09+155,450→ 155,450 total
Other
ACELYRIN, Inc.
Director Stock Option (right to buy)
2023-05-09−155,450→ 0 total
Purchase
ACELYRIN, Inc.
Common Stock
2023-05-09$18.00/sh+50,000→ 50,000 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2022-05-26+40,000→ 40,000 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-05-16$155.00/sh−83,960→ 41,623 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to Buy)
2022-05-16$54.86/sh−83,960→ 0 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-05-16$155.00/sh−83,960→ 16,623 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-05-16$54.86/sh+83,960→ 100,583 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to Buy)
2022-05-16$54.86/sh−83,960→ 0 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-05-16$54.86/sh+83,960→ 125,583 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-03-01$147.60/sh−5,167→ 20,723 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-03-01$146.81/sh−15,733→ 25,890 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-03-01$147.54/sh−5,596→ 51,027 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-03-01$148.71/sh−4,000→ 53,600 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-03-01$147.60/sh−5,167→ 57,600 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-03-01$146.81/sh−15,733→ 62,767 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-03-01$149.14/sh−1,101→ 41,623 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-03-01$149.38/sh−100→ 16,623 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-03-01$148.62/sh−8,303→ 42,724 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-03-01$149.38/sh−100→ 53,500 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-03-01$148.71/sh−4,000→ 16,723 total
Tax Payment
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-02-25$149.54/sh−30,156→ 56,623 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-02-17+7,972→ 63,356 total
Award
AbbVie Inc.$ABBV
Option (right to buy)
2022-02-17+30,647→ 30,647 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-02-17+36,673→ 55,384 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-02-17+8,701→ 86,779 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2022-02-17+14,722→ 78,078 total
Gift
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2021-09-07−30,000→ 18,711 total
Gift
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2021-09-07+30,000→ 78,500 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2021-05-27+40,000→ 40,000 total
Tax Payment
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2021-02-28$107.74/sh−22,833→ 48,711 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2021-02-18+7,972→ 56,820 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2021-02-18+22,287→ 42,293 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2021-02-18+14,724→ 71,544 total
Award
AbbVie Inc.$ABBV
Option(right to buy)
2021-02-18+49,068→ 49,068 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2021-02-18+6,555→ 48,848 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2020-12-31$2.22/sh+5,339→ 5,339 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par share
2020-11-20$98.83/sh−6,900→ 53,106 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par shar
2020-11-20$99.49/sh−33,100→ 20,006 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2020-09-30$2.16/sh+5,490→ 5,490 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2020-06-30$2.68/sh+4,051→ 4,051 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2020-05-20+40,000→ 40,000 total
Gift
AbbVie Inc.$ABBV
Common Stock, $0.01 par share
2020-04-06+18,500→ 48,500 total

Companies

Recent Filings

Address

C/O ACELYRIN, INC. 4149 LIBERTY CANYON RD.

AGOURA HILLS, CA, 91301

View on SEC.gov